| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.35 | 0.03 |